News H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Delayed Japan Exchange Other stock markets 02:00:00 2024-04-18 am EDT			5-day change	1st Jan Change
2,365 ^JPY	-1.05%		-1.95%	-11.21%

Mar. 13	H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field	MT
Mar. 13	Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Final dividend	Mar. 27	FA
H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field	Mar. 13	MT
Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics	Mar. 12	CI
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems	Dec. 22	CI
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook	Dec. 22	MT
H.U. Group to Issue Stock Options to Directors, Employees	Dec. 21	MT
H.U. Group to Grant Share Options to Staff	Nov. 19	MT
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 09	CI
Ex-dividend day for interim dividend	23-09-27	FA
H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index	23-09-18	CI
Recent DOJ Settlement With NextGen Highlights Continued Enforcement Focus On Electronic Health Records Technology Vendors	23-08-07	AQ
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47%	23-05-17	MT
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024	23-05-16	CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024	23-05-16	CI
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
H.U. Group Holdings Inc. - Fujirebio further extends its fully automated blood-based biomarker portfolio with the fully automated Lumipulse G ApoE4 and Lumipulse G Pan-ApoE assays for Research Use Only	23-04-03	AQ
Ex-dividend day for final dividend	23-03-29	FA
Fujirebio expands its assay menu in the field of neurodegenerative diseases with the launch of the fully automated Lumipulse G NfL CSF and Lumipulse G NfL Blood tests	23-03-29	AQ
H.U. Group Holdings, Inc. Announces Launch of the Fully Automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests	23-03-28	CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023	23-02-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Summary

Filters